+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sacubitril Valsartan Sodium Tablets Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Sacubitril Valsartan Sodium Tablets Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Sacubitril Valsartan Sodium Tablets Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6079763
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Executive Summary: Introduction to Sacubitril Valsartan Sodium Tablets Market Dynamics

The sacubitril valsartan sodium tablet has emerged as a cornerstone in the management of cardiovascular diseases, particularly heart failure and hypertension. Clinical evidence underscores its efficacy in improving patient outcomes by combining a neprilysin inhibitor with an angiotensin receptor blocker, offering superior mortality and morbidity benefits compared to traditional therapies. With the global population aging and the prevalence of chronic conditions rising, demand for innovative treatment options continues to accelerate. Moreover, healthcare systems are increasingly focused on value-based care, driving prescribers and payers to seek therapies that deliver both clinical and economic advantages. In this context, understanding the multifaceted dynamics of the sacubitril valsartan sodium market is essential for pharmaceutical executives, policy makers, and investors. This executive summary provides a comprehensive introduction to the forces shaping this market, including regulatory developments, competitive pressures, and evolving patient needs. By establishing a clear overview of current trends and challenges, we set the stage for deeper insights into segmentation, regional patterns, and actionable strategies for stakeholders aiming to secure a leadership position.

Transformative Shifts Reshaping the Sacubitril Valsartan Sodium Landscape

Over the past several years, transformative shifts have reshaped the landscape for sacubitril valsartan sodium tablets. Regulatory milestones, such as expanded approvals for heart failure with preserved ejection fraction and streamlined pathways for generic entrants, have altered competitive dynamics and accelerated market expansion. Simultaneously, the proliferation of real-world evidence platforms and digital health solutions has enabled more personalized therapy management and improved patient adherence. Telemedicine adoption has broadened access to specialist care, while supply chain innovations- including blockchain-enabled traceability and advanced cold chain logistics-have enhanced product integrity from manufacturing to patient delivery.

Moreover, healthcare payers are increasingly embracing value-based contracting models, linking reimbursement to patient outcomes and driving manufacturers to demonstrate tangible benefits in quality-adjusted life years. Partnerships between pharmaceutical companies and technology firms are emerging to develop companion diagnostics and remote monitoring tools that support dose optimization and early intervention. Altogether, these shifts demand agile strategies that align R&D pipelines, market access plans, and commercial operations with a fast-evolving ecosystem.

Cumulative Impact of United States Tariffs 2025 on Market Access and Pricing

The implementation of new United States tariffs in 2025 has introduced material headwinds for manufacturers of sacubitril valsartan sodium tablets. These levies, applied to key active pharmaceutical ingredients and specialized excipients sourced from international suppliers, have elevated input costs and compressed profit margins. In response, leading producers are reevaluating their supply chains through nearshoring initiatives, forging strategic alliances with domestic API manufacturers, and optimizing inventory management via just-in-time procurement.

At the same time, cost increases have prompted several companies to adjust wholesale acquisition costs, creating potential pricing pressures for payers and patients. To mitigate the impact, some organizations have pursued hedging strategies and multiyear supplier contracts to lock in favorable terms. In parallel, regulatory teams are expediting filings for alternative synthesis routes and exploring in-house manufacturing capabilities to reduce reliance on tariff-exposed imports. Collectively, these measures illustrate the adaptive maneuvers required to sustain market access and uphold competitive pricing in a tariff-impacted environment.

Key Segmentation Insights Driving Strategic Decision-Making

Granular segmentation insights illuminate where growth opportunities and competitive pressures converge within the sacubitril valsartan sodium market. By therapeutic application, chronic therapy management segments exhibit steady baseline demand, whereas heart failure management-encompassing both preserved and reduced ejection fraction indications-drives the most rapid adoption curve; hypertension remains a significant but more commoditized category. Examining patient demographics reveals that adult and elderly populations constitute the core user base, with pediatric usage still nascent; gender distribution skews marginally toward females, while at-risk patients command heightened clinical attention and prescribing intensity.

Distribution channel analysis highlights that hospital pharmacies continue to capture high-volume, acute-care demand, whereas retail pharmacies and specialty pharmacies facilitate outpatient adherence; online pharmacy channels, split between business-to-business and business-to-consumer platforms, are expanding rapidly as digital-native consumers and institutional buyers alike seek convenience and competitive pricing. The tablet strength portfolio-ranging from 24 mg/26 mg and 49 mg/51 mg to 97 mg/103 mg-enables tailored titration strategies aligned with patient tolerance and therapeutic goals. End-user landscapes span clinics, homecare settings, and hospitals, each displaying unique prescribing patterns and reimbursement protocols. Moreover, endorsements and recommendations from cardiology associations serve as critical trust markers, influencing formulary placement and guideline adoption. Price sensitivity analysis underscores the growing role of generic versions in driving volume growth against branded product premium positioning. Finally, therapeutic substitution dynamics highlight that alternatives such as ACE inhibitors, beta blockers, and calcium channel blockers remain viable competitive options, reinforcing the need for robust value communication and outcome data.

Regional Dynamics: Unraveling Key Insights Across Global Markets

Regional dynamics present distinct market characteristics and strategic considerations. In the Americas, robust reimbursement frameworks and an established prescribing culture for sacubitril valsartan sodium support rapid uptake, although pricing scrutiny by payers necessitates compelling pharmacoeconomic evidence. The Europe, Middle East & Africa region features heterogeneous regulatory environments: Western Europe leverages centralized approval pathways and strong patient advocacy, while Middle Eastern and African markets exhibit varied procurement models and growing emphasis on local manufacturing partnerships.

Meanwhile, Asia-Pacific markets display divergent growth trajectories. In mature economies such as Japan and Australia, structured formularies and aging populations drive stable demand; in emerging markets like China and India, expanding healthcare coverage and rising cardiovascular disease prevalence create significant expansion potential for both branded and generic formulations. Cross-region collaboration on clinical trials, licensing deals, and supply agreements is increasingly common as companies seek to harmonize regulatory dossiers and leverage volume synergies across multiple jurisdictions.

Competitive Landscape: Insights on Leading Industry Players

The competitive landscape is characterized by a blend of global pharmaceutical giants and agile regional players. Among the leading innovators, Novartis International AG and Pfizer Inc. remain at the forefront of product development and global commercialization strategies, leveraging extensive clinical networks and brand recognition. Meanwhile, Teva Pharmaceutical Industries Ltd. and Mylan N.V. (now part of Viatris) have capitalized on patent expirations to introduce cost-competitive generic formulations.

Regional champions such as Cipla Limited, Dr. Reddy's Laboratories Ltd., and Sun Pharmaceutical Industries Ltd. are deploying robust manufacturing footprints and localized regulatory expertise to capture market share in key emerging economies. Alkem Laboratories Ltd., Aurobindo Pharma Limited, Glenmark Pharmaceuticals Ltd., Hetero Labs Limited, Lupin Limited, Torrent Pharmaceuticals Ltd., and Zydus Cadila (Cadila Healthcare Ltd.) are similarly pursuing differentiated value propositions-ranging from tiered pricing schemes to co-development partnerships-to solidify their presence. Collectively, these players are balancing strategic alliances, portfolio expansions, and cost optimization initiatives to navigate a dynamic market environment and anticipate future shifts.

Actionable Recommendations for Industry Leaders to Capitalize on Growth Opportunities

To capitalize on evolving market conditions, industry leaders should adopt a multifaceted approach. First, prioritize portfolio diversification by accelerating the development of generic equivalents alongside innovative formulations and dosage strengths. Second, enhance patient engagement through digital therapeutics and remote monitoring solutions, integrating telehealth platforms to improve adherence and capture real-world data for outcome validation. Third, engage proactively with cardiology associations to secure guideline endorsements and bolster formulary placements.

Fourth, refine supply chain resilience by diversifying sourcing across geographies, implementing advanced demand forecasting algorithms, and negotiating long-term supplier agreements to mitigate tariff volatility. Fifth, tailor regional go-to-market strategies by aligning with local reimbursement frameworks, forging strategic licensing and manufacturing collaborations in high-growth Asia-Pacific and EMEA markets, and leveraging value-based contracting mechanisms in the Americas. Sixth, forge partnerships with healthcare technology firms to develop companion diagnostic tools and digital adherence solutions, thereby creating integrated offerings that address provider and patient pain points.

Conclusion: Navigating Future Pathways in Sacubitril Valsartan Sodium Market

The sacubitril valsartan sodium tablet market stands at a crossroads of clinical innovation, regulatory evolution, and competitive dynamism. Stakeholders must embrace data-driven decision-making, foster cross-functional collaboration between R&D, commercial, and access teams, and maintain strategic agility in response to tariff fluctuations and shifting reimbursement landscapes. By leveraging robust segmentation insights, regional intelligence, and competitive benchmarking, companies can craft targeted strategies that maximize patient impact and sustainable revenue growth. Ultimately, success will hinge on the ability to deliver differentiated value propositions-whether through advanced dosage formulations, enhanced digital support services, or outcome-based partnerships-while navigating an increasingly complex global ecosystem.

Market Segmentation & Coverage

This research report categorizes the Sacubitril Valsartan Sodium Tablets Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Chronic Therapy Management
  • Heart Failure Management
    • Preserved Ejection Fraction
    • Reduced Ejection Fraction
  • Hypertension
  • Age Group
    • Adult
    • Elderly
    • Pediatric
  • Gender
    • Female
    • Male
  • Health Status
    • At-Risk Patients
    • Normal Risk Patients
  • Hospital Pharmacies
  • Online Pharmacies
    • B2B Platforms
    • B2C Platforms
  • Retail Pharmacies
  • Specialty Pharmacies
  • Tablet Strength
    • 24 mg/26 mg
    • 49 mg/51 mg
    • 97 mg/103 mg
  • Clinics
  • Homecare Settings
  • Hospitals
  • Endorsements
  • Recommendations
  • Branded Product
  • Generic Versions
  • Use of Alternatives
    • ACE Inhibitors
    • Beta Blockers
    • Calcium Channel Blockers

This research report categorizes the Sacubitril Valsartan Sodium Tablets Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Sacubitril Valsartan Sodium Tablets Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Alkem Laboratories Ltd.
  • Aurobindo Pharma Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Hetero Labs Limited
  • Lupin Limited
  • Mylan N.V. (now part of Viatris)
  • Novartis International AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Zydus Cadila (Cadila Healthcare Ltd.)

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Sacubitril Valsartan Sodium Tablets Market, by Therapeutic Application
8.1. Introduction
8.2. Chronic Therapy Management
8.3. Heart Failure Management
8.3.1. Preserved Ejection Fraction
8.3.2. Reduced Ejection Fraction
8.4. Hypertension
9. Sacubitril Valsartan Sodium Tablets Market, by Patient Demographics
9.1. Introduction
9.2. Age Group
9.2.1. Adult
9.2.2. Elderly
9.2.3. Pediatric
9.3. Gender
9.3.1. Female
9.3.2. Male
9.4. Health Status
9.4.1. At-Risk Patients
9.4.2. Normal Risk Patients
10. Sacubitril Valsartan Sodium Tablets Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.3.1. B2B Platforms
10.3.2. B2C Platforms
10.4. Retail Pharmacies
10.5. Specialty Pharmacies
11. Sacubitril Valsartan Sodium Tablets Market, by Dosage Formulation
11.1. Introduction
11.2. Tablet Strength
11.2.1. 24 mg/26 mg
11.2.2. 49 mg/51 mg
11.2.3. 97 mg/103 mg
12. Sacubitril Valsartan Sodium Tablets Market, by End-User
12.1. Introduction
12.2. Clinics
12.3. Homecare Settings
12.4. Hospitals
13. Sacubitril Valsartan Sodium Tablets Market, by Cardiology Associations
13.1. Introduction
13.2. Endorsements
13.3. Recommendations
14. Sacubitril Valsartan Sodium Tablets Market, by Price Sensitivity
14.1. Introduction
14.2. Branded Product
14.3. Generic Versions
15. Sacubitril Valsartan Sodium Tablets Market, by Therapeutic Substitution
15.1. Introduction
15.2. Use of Alternatives
15.2.1. ACE Inhibitors
15.2.2. Beta Blockers
15.2.3. Calcium Channel Blockers
16. Americas Sacubitril Valsartan Sodium Tablets Market
16.1. Introduction
16.2. Argentina
16.3. Brazil
16.4. Canada
16.5. Mexico
16.6. United States
17. Asia-Pacific Sacubitril Valsartan Sodium Tablets Market
17.1. Introduction
17.2. Australia
17.3. China
17.4. India
17.5. Indonesia
17.6. Japan
17.7. Malaysia
17.8. Philippines
17.9. Singapore
17.10. South Korea
17.11. Taiwan
17.12. Thailand
17.13. Vietnam
18. Europe, Middle East & Africa Sacubitril Valsartan Sodium Tablets Market
18.1. Introduction
18.2. Denmark
18.3. Egypt
18.4. Finland
18.5. France
18.6. Germany
18.7. Israel
18.8. Italy
18.9. Netherlands
18.10. Nigeria
18.11. Norway
18.12. Poland
18.13. Qatar
18.14. Russia
18.15. Saudi Arabia
18.16. South Africa
18.17. Spain
18.18. Sweden
18.19. Switzerland
18.20. Turkey
18.21. United Arab Emirates
18.22. United Kingdom
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Alkem Laboratories Ltd.
19.3.2. Aurobindo Pharma Limited
19.3.3. Cipla Limited
19.3.4. Dr. Reddy's Laboratories Ltd.
19.3.5. Glenmark Pharmaceuticals Ltd.
19.3.6. Hetero Labs Limited
19.3.7. Lupin Limited
19.3.8. Mylan N.V. (now part of Viatris)
19.3.9. Novartis International AG
19.3.10. Pfizer Inc.
19.3.11. Sun Pharmaceutical Industries Ltd.
19.3.12. Teva Pharmaceutical Industries Ltd.
19.3.13. Torrent Pharmaceuticals Ltd.
19.3.14. Zydus Cadila (Cadila Healthcare Ltd.)
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. SACUBITRIL VALSARTAN SODIUM TABLETS MARKET MULTI-CURRENCY
FIGURE 2. SACUBITRIL VALSARTAN SODIUM TABLETS MARKET MULTI-LANGUAGE
FIGURE 3. SACUBITRIL VALSARTAN SODIUM TABLETS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORMULATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CARDIOLOGY ASSOCIATIONS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CARDIOLOGY ASSOCIATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRICE SENSITIVITY, 2024 VS 2030 (%)
FIGURE 20. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRICE SENSITIVITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC SUBSTITUTION, 2024 VS 2030 (%)
FIGURE 22. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC SUBSTITUTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. SACUBITRIL VALSARTAN SODIUM TABLETS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CHRONIC THERAPY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEART FAILURE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRESERVED EJECTION FRACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY REDUCED EJECTION FRACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY AGE GROUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEALTH STATUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY AT-RISK PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY NORMAL RISK PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEALTH STATUS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY B2B PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY B2C PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY TABLET STRENGTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY 24 MG/26 MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY 49 MG/51 MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY 97 MG/103 MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY TABLET STRENGTH, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CARDIOLOGY ASSOCIATIONS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ENDORSEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY RECOMMENDATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRICE SENSITIVITY, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY BRANDED PRODUCT, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GENERIC VERSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC SUBSTITUTION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY USE OF ALTERNATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ACE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY BETA BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY USE OF ALTERNATIVES, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEALTH STATUS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY TABLET STRENGTH, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CARDIOLOGY ASSOCIATIONS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRICE SENSITIVITY, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC SUBSTITUTION, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY USE OF ALTERNATIVES, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEALTH STATUS, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY TABLET STRENGTH, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CARDIOLOGY ASSOCIATIONS, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRICE SENSITIVITY, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC SUBSTITUTION, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY USE OF ALTERNATIVES, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEALTH STATUS, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY TABLET STRENGTH, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CARDIOLOGY ASSOCIATIONS, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRICE SENSITIVITY, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC SUBSTITUTION, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY USE OF ALTERNATIVES, 2018-2030 (USD MILLION)
TABLE 103. CANADA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. CANADA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 105. CANADA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 106. CANADA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 107. CANADA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 108. CANADA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEALTH STATUS, 2018-2030 (USD MILLION)
TABLE 109. CANADA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. CANADA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 111. CANADA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
TABLE 112. CANADA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY TABLET STRENGTH, 2018-2030 (USD MILLION)
TABLE 113. CANADA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. CANADA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CARDIOLOGY ASSOCIATIONS, 2018-2030 (USD MILLION)
TABLE 115. CANADA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRICE SENSITIVITY, 2018-2030 (USD MILLION)
TABLE 116. CANADA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC SUBSTITUTION, 2018-2030 (USD MILLION)
TABLE 117. CANADA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY USE OF ALTERNATIVES, 2018-2030 (USD MILLION)
TABLE 118. MEXICO SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. MEXICO SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 120. MEXICO SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 121. MEXICO SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 122. MEXICO SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 123. MEXICO SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEALTH STATUS, 2018-2030 (USD MILLION)
TABLE 124. MEXICO SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. MEXICO SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 126. MEXICO SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
TABLE 127. MEXICO SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY TABLET STRENGTH, 2018-2030 (USD MILLION)
TABLE 128. MEXICO SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. MEXICO SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CARDIOLOGY ASSOCIATIONS, 2018-2030 (USD MILLION)
TABLE 130. MEXICO SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRICE SENSITIVITY, 2018-2030 (USD MILLION)
TABLE 131. MEXICO SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC SUBSTITUTION, 2018-2030 (USD MILLION)
TABLE 132. MEXICO SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY USE OF ALTERNATIVES, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 137. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEALTH STATUS, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY TABLET STRENGTH, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CARDIOLOGY ASSOCIATIONS, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRICE SENSITIVITY, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC SUBSTITUTION, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY USE OF ALTERNATIVES, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 151. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 152. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 153. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 154. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEALTH STATUS, 2018-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
TABLE 158. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY TABLET STRENGTH, 2018-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CARDIOLOGY ASSOCIATIONS, 2018-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRICE SENSITIVITY, 2018-2030 (USD MILLION)
TABLE 162. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC SUBSTITUTION, 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY USE OF ALTERNATIVES, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 165. AUSTRALIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. AUSTRALIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 167. AUSTRALIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 168. AUSTRALIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 169. AUSTRALIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 170. AUSTRALIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEALTH STATUS, 2018-2030 (USD MILLION)
TABLE 171. AUSTRALIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. AUSTRALIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 173. AUSTRALIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
TABLE 174. AUSTRALIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY TABLET STRENGTH, 2018-2030 (USD MILLION)
TABLE 175. AUSTRALIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. AUSTRALIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CARDIOLOGY ASSOCIATIONS, 2018-2030 (USD MILLION)
TABLE 177. AUSTRALIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRICE SENSITIVITY, 2018-2030 (USD MILLION)
TABLE 178. AUSTRALIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC SUBSTITUTION, 2018-2030 (USD MILLION)
TABLE 179. AUSTRALIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY USE OF ALTERNATIVES, 2018-2030 (USD MILLION)
TABLE 180. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 182. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 183. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 184. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 185. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEALTH STATUS, 2018-2030 (USD MILLION)
TABLE 186. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 188. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
TABLE 189. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY TABLET STRENGTH, 2018-2030 (USD MILLION)
TABLE 190. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CARDIOLOGY ASSOCIATIONS, 2018-2030 (USD MILLION)
TABLE 192. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRICE SENSITIVITY, 2018-2030 (USD MILLION)
TABLE 193. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC SUBSTITUTION, 2018-2030 (USD MILLION)
TABLE 194. CHINA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY USE OF ALTERNATIVES, 2018-2030 (USD MILLION)
TABLE 195. INDIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. INDIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 197. INDIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 198. INDIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 199. INDIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 200. INDIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEALTH STATUS, 2018-2030 (USD MILLION)
TABLE 201. INDIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. INDIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 203. INDIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
TABLE 204. INDIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY TABLET STRENGTH, 2018-2030 (USD MILLION)
TABLE 205. INDIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. INDIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CARDIOLOGY ASSOCIATIONS, 2018-2030 (USD MILLION)
TABLE 207. INDIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRICE SENSITIVITY, 2018-2030 (USD MILLION)
TABLE 208. INDIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC SUBSTITUTION, 2018-2030 (USD MILLION)
TABLE 209. INDIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY USE OF ALTERNATIVES, 2018-2030 (USD MILLION)
TABLE 210. INDONESIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. INDONESIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 212. INDONESIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 213. INDONESIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 214. INDONESIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 215. INDONESIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEALTH STATUS, 2018-2030 (USD MILLION)
TABLE 216. INDONESIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. INDONESIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 218. INDONESIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
TABLE 219. INDONESIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY TABLET STRENGTH, 2018-2030 (USD MILLION)
TABLE 220. INDONESIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 221. INDONESIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CARDIOLOGY ASSOCIATIONS, 2018-2030 (USD MILLION)
TABLE 222. INDONESIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRICE SENSITIVITY, 2018-2030 (USD MILLION)
TABLE 223. INDONESIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC SUBSTITUTION, 2018-2030 (USD MILLION)
TABLE 224. INDONESIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY USE OF ALTERNATIVES, 2018-2030 (USD MILLION)
TABLE 225. JAPAN SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. JAPAN SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 227. JAPAN SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 228. JAPAN SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 229. JAPAN SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 230. JAPAN SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEALTH STATUS, 2018-2030 (USD MILLION)
TABLE 231. JAPAN SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. JAPAN SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 233. JAPAN SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
TABLE 234. JAPAN SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY TABLET STRENGTH, 2018-2030 (USD MILLION)
TABLE 235. JAPAN SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. JAPAN SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CARDIOLOGY ASSOCIATIONS, 2018-2030 (USD MILLION)
TABLE 237. JAPAN SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRICE SENSITIVITY, 2018-2030 (USD MILLION)
TABLE 238. JAPAN SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC SUBSTITUTION, 2018-2030 (USD MILLION)
TABLE 239. JAPAN SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY USE OF ALTERNATIVES, 2018-2030 (USD MILLION)
TABLE 240. MALAYSIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. MALAYSIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 242. MALAYSIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 243. MALAYSIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 244. MALAYSIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 245. MALAYSIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEALTH STATUS, 2018-2030 (USD MILLION)
TABLE 246. MALAYSIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. MALAYSIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 248. MALAYSIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
TABLE 249. MALAYSIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY TABLET STRENGTH, 2018-2030 (USD MILLION)
TABLE 250. MALAYSIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 251. MALAYSIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CARDIOLOGY ASSOCIATIONS, 2018-2030 (USD MILLION)
TABLE 252. MALAYSIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRICE SENSITIVITY, 2018-2030 (USD MILLION)
TABLE 253. MALAYSIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC SUBSTITUTION, 2018-2030 (USD MILLION)
TABLE 254. MALAYSIA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY USE OF ALTERNATIVES, 2018-2030 (USD MILLION)
TABLE 255. PHILIPPINES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. PHILIPPINES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 257. PHILIPPINES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 258. PHILIPPINES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 259. PHILIPPINES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 260. PHILIPPINES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEALTH STATUS, 2018-2030 (USD MILLION)
TABLE 261. PHILIPPINES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. PHILIPPINES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 263. PHILIPPINES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
TABLE 264. PHILIPPINES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY TABLET STRENGTH, 2018-2030 (USD MILLION)
TABLE 265. PHILIPPINES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 266. PHILIPPINES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CARDIOLOGY ASSOCIATIONS, 2018-2030 (USD MILLION)
TABLE 267. PHILIPPINES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRICE SENSITIVITY, 2018-2030 (USD MILLION)
TABLE 268. PHILIPPINES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC SUBSTITUTION, 2018-2030 (USD MILLION)
TABLE 269. PHILIPPINES SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY USE OF ALTERNATIVES, 2018-2030 (USD MILLION)
TABLE 270. SINGAPORE SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. SINGAPORE SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEART FAILURE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 272. SINGAPORE SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 273. SINGAPORE SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 274. SINGAPORE SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 275. SINGAPORE SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY HEALTH STATUS, 2018-2030 (USD MILLION)
TABLE 276. SINGAPORE SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. SINGAPORE SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 278. SINGAPORE SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY DOSAGE FORMULATION, 2018-2030 (USD MILLION)
TABLE 279. SINGAPORE SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY TABLET STRENGTH, 2018-2030 (USD MILLION)
TABLE 280. SINGAPORE SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 281. SINGAPORE SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY CARDIOLOGY ASSOCIATIONS, 2018-2030 (USD MILLION)
TABLE 282. SINGAPORE SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY PRICE SENSITIVITY, 2018-2030 (USD MILLION)
TABLE 283. SINGAPORE SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC SUBSTITUTION, 2018-2030 (USD MILLION)
TABLE 284. SINGAPORE SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY USE OF ALTERNATIVES, 2018-2030 (USD MILLION)
TABLE 285. SOUTH KOREA SACUBITRIL VALSARTAN SODIUM TABLETS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. SOUTH KOREA SA

Companies Mentioned

  • Alkem Laboratories Ltd.
  • Aurobindo Pharma Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Hetero Labs Limited
  • Lupin Limited
  • Mylan N.V. (now part of Viatris)
  • Novartis International AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Zydus Cadila (Cadila Healthcare Ltd.)

Methodology

Loading
LOADING...

Related Topics

Related Reports

Angiotensin Receptor Blockers (ARBs) Market Report 2025 - Product Image

Angiotensin Receptor Blockers (ARBs) Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Chronic Heart Failure - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Chronic Heart Failure - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 331 Pages
  • Global
From
Valsartan (CAS 137862-53-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Valsartan (CAS 137862-53-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Heart Failure Drugs - Global Strategic Business Report - Product Image

Heart Failure Drugs - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Anti-Hypertensive Drugs Market Report 2025 - Product Image

Anti-Hypertensive Drugs Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.